OCSAW Oculis Holding AG Warrants
$4.10▲ +0.00%
Unknown
Other
Volume 998
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
3.83 - 4.10
% vs 50 MA
-65.55%
% vs 200 MA
–%
RSI-14
40.3
MACD Histogram
+0.2900
Beta (1Y vs SPY)
-1.10
Free Cash Flow
-$20.25M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$22.80M
COGS
–
Operating Exp
$23.57M
Operating Income
-$23.57M
EBIT
-$23.57M
Pretax Income
-$9.96M
Net Income
-$9.97M
Price & Volume History
Loading chart…
Recent News

Wall Street Analysts Believe Oculis Holding AG (OCS) Could Rally 199.75%: Here's is How to Trade
Zacks · Aug 31, 2026 1:55 PM
Oculis Treats First Patient in Optic Neuritis Trial; Shares Up Pre-Bell
MT Newswires · Aug 24, 2026 9:41 AM

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
GlobeNewswire · Aug 14, 2026 8:05 PM

Does Oculis Holding AG (OCS) Have the Potential to Rally 187.83% as Wall Street Analysts Expect?
Zacks · Aug 14, 2026 1:55 PM
Oculis to Buy Accure's Global Development, Commercial Rights to Privosegtor
MT Newswires · Aug 10, 2026 8:45 AM
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company
GlobeNewswire · Aug 10, 2026 7:30 AM
Oculis Holding AG (OCS) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 7, 2026 2:35 AM
Oculis Reports Q2 2026 Financial Results and Provides Company Update
GlobeNewswire · Aug 6, 2026 8:05 PM
Earnings To Watch: Oculis Holding AG (OCS) Reports Q2 2026 Result
GuruFocus.com · Aug 5, 2026 1:33 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See OCSAW's money flow as a full page
Social Sentiment
No Reddit posts found for OCSAW.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.